[The effect of the SKN charcoal enterosorbent on the clinico-laboratory indices of patients with chronic circulatory failure].
A total of 85 patients presenting with chronic stage II A-II B circulatory insufficiency were studied to find out whether it is possible to combine cardiac glycosides (digoxin and strophanthin) under their parenteral administration with peroral course intake of the enterosorbent SKN as treatment of ischemic heart disease. Combination of cardiac glycosides with SKN was found to make for enhancement of efficiency of cardiotonic therapy, with the presentation of the dyspeptic syndrome getting more attenuated, cardiac arrhythmias becoming less frequent, hypercholesterinemia, hyperbetalipoproteidemia less apparent, cardiohemodynamics and central hemodynamics improved, ATP concentration in blood erythrocytes increased.
Nykula
T D
TD
Bondur
V V
VV
Pluzhnyk
K H
KH
D000368:Aged; D000369:Aged, 80 and over; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002606:Charcoal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016061:Enterosorption; D006333:Heart Failure / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy
D002301:Cardiac Glycosides; C029814:SKN hemosorbents; D002606:Charcoal
Vplyv vuhletsevoho enterosorbentu SKN na kliniko-laboratorni pokaznyky u khvorykh z khronichnoiu nedostatnistiu krovoobihu.